Mitochondrial superoxide in osteocytes perturbs canalicular networks in the setting of age-related osteoporosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kobayashi, Keiji ^a,b   Nojiri, Hidetoshi ^b   Saita, Yoshitomo ^b   Morikawa, Daichi ^a,b   Ozawa, Yusuke ^a   Watanabe, Kenji ^a   Koike, Masato ^a,b   Asou, Yoshinori ^c   Shirasawa, Takuji ^b   Yokote, Koutaro ^a   Kaneko, Kazuo ^b   Shimizu, Takahiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MANGANESE SUPEROXIDE DISMUTASE; OSTEOCLAST DIFFERENTIATION FACTOR; SOST PROTEIN, MOUSE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL; BONE DEVELOPMENT; CELL LINE; CELL SURVIVAL; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MITOCHONDRION; MOUSE; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; BONE RESORPTION; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLYCOPROTEINS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA; OSTEOCYTES; OSTEOGENESIS; OSTEOPOROSIS; RANK LIGAND; SUPEROXIDE DISMUTASE; SUPEROXIDES; UP-REGULATION; X-RAY MICROTOMOGRAPHY;

EID: 84924975774     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09148     Document Type: Article

References (39)

1. Khosla, S., Oursler, M. J. & Monroe, D. G. Estrogen and the skeleton. Trends in endocrinology and metabolism: TEM 23, 576-581 (2012).
2. Bonewald, L. F. The amazing osteocyte. J Bone Miner Res 26, 229-238 (2011).
3. Dunstan, C. R., Somers, N. M. & Evans, R. A. Osteocyte death and hip fracture. Calcif Tissue Int 53, S113-116 (1993).
4. Busse, B. et al . Decrease in the osteocyte lacunar density accompanied by hypermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone. Aging Cell 9, 1065-1075 (2010).
5. Milovanovic, P. et al. Osteocytic Canalicular Networks Morphological implications for altered mechanosensitivity. acsNANO 7, 7542-7551 (2013).
6. Almeida, M. et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282, 27285-27297 (2007).
7. Almeida, M., Ambrogini, E.,Han, L., Manolagas, S. C. & Jilka, R. L. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem 284, 27438-27448 (2009).
8. Nojiri, H. et al. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res 26, 2682-2694 (2011).
9. Almeida, M. & O'Brien, C. A. Basic biology of skeletal aging: role of stress response pathways. J Gerontol A Biol Sci Med Sci 68, 1197-1208 (2013).
10. Droge, W. Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95 (2002).
11. Ikegami, T. et al. Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene. Biochem Biophys Res Commun 296, 729-736 (2002).
12. Nojiri, H. et al. Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem 281, 33789-33801 (2006).
13. Kuwahara, H. et al. Oxidative stress in skeletal muscle causes severe disturbance of exercise activity without muscle atrophy. Free Radic Biol Med 48, 1252-1262 (2010).
14. Shimizu, T., Nojiri, H., Kawakami, S., Uchiyama, S. & Shirasawa, T. Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatr Gerontol Int 10, S70-79 (2010).
15. Xiao, Z. et al. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice. FASEB J 25, 2418-2432 (2011).
16. Xiao, Z. et al. Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23. PLOS ONE 9, e104154 (2014)
17. Stern, A. R. et al. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 52, 361-373 (2012).
18. Cocheme, H. M. & Murphy, M. P. Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283, 1786-1798 (2008).
19. Sato, N. et al. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med 200, 601-611 (2004).
20. Basu, S., Michaelsson, K., Olofsson, H., Johansson, S. & Melhus, H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288, 275-279 (2001).
21. Maggio, D. et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88, 1523-1527 (2003).
22. Almeida, M. et al . Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalpha. J Bone Miner Res 25, 769-781 (2010).
23. Morikawa, D. et al. Cytoplasmic reactive oxygen species and SOD1 regulate bone mass during mechanical unloading. J Bone Miner Res 28, 2368-2380 (2013).
24. Imai, Y. et al. Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch. Cell Rep 7, 194-207 (2014).
25. Tatsumi, S. et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab 5, 464-475 (2007).
26. Spatz, J. M. et al. Serum sclerostin increases in healthy adult men during bed rest. J Clin Endocrinol Metab 97, E1736-1740 (2012).
27. Chen, H., Shoumura, S. & Emura, S. Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis. Cell Mol Biol 19, 677-685 (2004).
28. Kawakami, S. et al. Antioxidant, EUK-8, Prevents Murine Dilated Cardiomyopathy. Cir J 73, 2125-2134 (2009).
29. Baek, K. et al. TNF-alpha upregulates sclerostin expression in obese mice fed a high-fat diet. J Cell physiol 229, 640-650 (2014).
30. Bai, X. C. et al. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280, 17497-17506 (2005).
31. Takami, M. et al. Intracellular calcium and protein kinase Cmediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology 141, 4711-4719 (2000).
32. Kogianni, G.,Mann, V. & Noble, B. S. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res 23, 915-927 (2008).
33. Miyazaki, T., Tokimura, F. & Tanaka, S. A review of denosumab for the treatment of osteoporosis. Patient Prefer Adherence 8, 463-471 (2014).
34. Padhi, D., Jang, G., Stouch, B., Fang, L. & Posvar, E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26, 19-26 (2011).
35. Lu, Y. et al. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res 86, 320-325 (2007).
36. Kawamoto, S. et al. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett 470, 263-268 (2000).
37. Kawamoto, T.&Shimizu, M.Amethod for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol 113, 331-339 (2000).
38. Frost, H. M. Preparation of thin undecalcified bone sections by rapid manual method. Stain Technol 33, 273-277 (1958).
39. Kato, Y. et al. Establishment of an Osteocyte-like Cell Line, MLO-Y4. J Bone Miner Res 12, 2014-2023 (1997).